#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15406	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2692	705.9	0	.	n	.	0	A69G	SNP	69	69	A	573	573	G	969	G,T,A	967,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15406	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2692	705.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1954	1954	T	992	T,C	990,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15406	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2692	705.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1688	1688	C	987	C,T,G,A	984,1,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26646	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4098	810.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1926	1926	A	1098	A,C	1096,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26646	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4098	810.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2560	2560	C	981	C,T,G	979,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26646	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4098	810.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2634	2634	A	931	A,T,C	929,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26646	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4098	810.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3186	3186	C	901	C,T,G	899,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	2384	folP	852	852	99.88	folP.l15.c4.ctg.1	2027	146.1	0	.	p	.	0	E151K	NONSYN	451	453	GAA	977	979	AAA	235;235;232	A;A;A,C,T	235;235;229,2,1	.	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	2384	folP	852	852	99.88	folP.l15.c4.ctg.1	2027	146.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1208	1210	AGC	234;236;234	A,G;G;C,G	233,1;236;233,1	folP.WHO_G_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5704	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3980	178.5	1	SNP	p	S91F	0	.	.	271	273	TCC	909	911	TCC	211;210;207	T;C;C,T	211;210;206,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5704	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3980	178.5	1	SNP	p	D95G	0	.	.	283	285	GAC	921	923	GAC	215;216;215	G,T;A;C	214,1;216;215	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5704	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3980	178.5	1	SNP	p	D95N	0	.	.	283	285	GAC	921	923	GAC	215;216;215	G,T;A;C	214,1;216;215	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	2066	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1723	149.2	1	SNP	p	G45D	0	.	.	133	135	GGC	696	698	GGC	227;230;231	G;G;C	227;230;231	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1094	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1490	91.6	0	.	n	.	0	A197.	DEL	197	197	A	861	861	A	206	A,T	205,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5488	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3511	194.8	1	SNP	p	D86N	0	.	.	256	258	GAC	881	883	GAC	237;237;238	G;A;C,A	237;237;237,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5488	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3511	194.8	1	SNP	p	S87R	0	.	.	259	261	AGT	884	886	AGT	238;236;237	A;G;T	238;236;237	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5488	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3511	194.8	1	SNP	p	S87W	0	.	.	259	261	AGT	884	886	AGT	238;236;237	A;G;T	238;236;237	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5488	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3511	194.8	1	SNP	p	S87I	0	.	.	259	261	AGT	884	886	AGT	238;236;237	A;G;T	238;236;237	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5488	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3511	194.8	1	SNP	p	S88P	0	.	.	262	264	TCC	887	889	TCC	235;236;239	T;C,G;C	235;234,2;239	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4634	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3091	186.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1791	1793	GGC	248;247;244	G,A;G,C;C	247,1;244,3;244	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4202	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2767	188.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1474	1476	GCA	226;229;228	G;C,A;A	226;228,1;228	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4202	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2767	188.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1477	1479	ATC	227;227;229	A,C;T;C	225,2;227;229	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4202	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2767	188.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1489	1491	GTG	242;241;243	G,A;T,G;G	241,1;240,1;243	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4202	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2767	188.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1489	1491	GTG	242;241;243	G,A;T,G;G	241,1;240,1;243	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4202	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2767	188.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1993	1995	ACC	255;257;256	A,T;C,T;C	254,1;256,1;256	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4202	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2767	188.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2047	2049	GCG	244;242;242	G;C,G;G	243;240,1;241	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4202	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2767	188.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2047	2049	GCG	244;242;242	G;C,G;G	243;240,1;241	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4202	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2767	188.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2170	2172	GGC	230;230;230	G,T;G,C;C,A	229,1;229,1;229,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4202	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2767	188.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2179	2181	GGC	232;232;232	G,T,A;G;C	230,1,1;232;232	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4202	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2767	188.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2197	2199	CTG	232;230;232	C,T,G;T,C;G	230,1,1;229,1;232	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5976	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3473	214.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1782	1784	CCG	214;215;217	C,T;C,T;G,T,C	213,1;214,1;215,1,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2764	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2332	147.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	795	795	C	197	C	197	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	111	92.79	porB1a.l15.c17.ctg.1	278	30.9	0	.	p	.	0	M18T	NONSYN	52	54	ATG	127	129	ACG	56;53;53	A,G;C;G	55,1;53;53	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	111	92.79	porB1a.l15.c17.ctg.1	278	30.9	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	169	171	CAA	17;16;16	C;A;A	17;16;16	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	111	92.79	porB1a.l15.c17.ctg.1	278	30.9	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	175	177	TAC	7;4;1	T;A;C	7;4;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	294	18.7	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	14;15;17	T;T;A	14;15;17	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	294	18.7	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	39;39;39	C;A,T;T	39;38,1;39	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	294	18.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	39;39;39	A;G;T	39;39;39	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	294	18.7	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	39;39;39	T;A;C,T	39;39;38,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	294	18.7	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	294	18.7	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	294	18.7	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	2;2;2	G;A;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	294	18.7	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	2;2;2	A;T;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	294	18.7	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	2;2;2	T;C;G	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	294	18.7	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	294	18.7	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	3;4;4	A;G;C	3;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	294	18.7	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	234	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	294	18.7	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	4;4;4	G;T;T	4;4;4	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2696	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1894	176.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	575	577	GAA	257;256;257	G;A;A	257;256;257	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2696	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1894	176.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	863	865	GAT	234;233;232	G;A,C;T,C	233;232,1;231,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2696	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1894	176.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	986	988	TCA	218;218;217	T;C,T;A	218;217,1;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2696	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1894	176.5	0	.	p	.	0	K207E	NONSYN	619	621	AAA	1082	1084	GAA	256;256;252	G;A;A,C	256;256;251,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2696	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1894	176.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1115	1117	GTC	224;222;217	G,C;T,G;C	223,1;221,1;216	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2696	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1894	176.5	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1127	1129	TCT	209;209;207	T;C;T	209;208;206	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2696	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1894	176.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1445	1447	GCA	192;188;191	G;C,G;A	192;186,1;191	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2696	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1894	176.5	1	SNP	p	G120K	1	.	.	358	360	AAG	821	823	AAG	231;233;235	A;A;G,A	231;233;234,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2696	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1894	176.5	1	SNP	p	D121N	0	.	.	361	363	GAC	824	826	GAC	238;238;241	G,T,A;A;C,A	236,1,1;238;240,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2696	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1894	176.5	1	SNP	p	A121D	1	.	.	361	363	GAC	824	826	GAC	238;238;241	G,T,A;A;C,A	236,1,1;238;240,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10042	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5481	228.5	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2257	2259	AAT	250;248;249	A;A;T	250;248;249	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1512	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1638	115.2	1	SNP	p	V57M	1	.	.	169	171	ATG	824	826	ATG	275;278;280	A;T;G,T	275;278;278,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
